Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 150 Stomach Neoplasms 52 Neoplasms 49 Pancreatic Neoplasms 41 Neoplasm Metastasis 32 Squamous Cell Carcinoma of Head and Neck 26 Head and Neck Neoplasms 25 Esophageal Neoplasms 24 Colonic Neoplasms 22 Rectal Neoplasms 21 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 20 Parkinson Disease 4, Autosomal Dominant Lewy Body 19 Esophageal Squamous Cell Carcinoma 15 Adenocarcinoma 14 Adenocarcinoma Of Esophagus 12 Cholangiocarcinoma 11 Biliary Tract Neoplasms 11 Ovarian Neoplasms 9 Triple Negative Breast Neoplasms 7 Gallbladder Neoplasms 7 Carcinoma, Hepatocellular 7 Carcinoma 7 Urinary Bladder Neoplasms 6 Sarcoma 6 Keratosis, Actinic 6 Gastrointestinal Neoplasms 6 Endometrial Neoplasms 6 Carcinoma, Squamous Cell 6 Advanced Solid Tumors 6

Interventions

Nivolumab 5 Ipilimumab 3 relatlimab 1 daratumumab 1 Fluorouracil 1 Cisplatin 1 BMS-986115 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Various Advanced Cancer × Fluorouracil × Clear all

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡